Skip to content

Performance and Safety Use of the Mono Block Implant KONTACT MB

Multicenter Observational Study on Performance and Safety Use of KONTACT MB Dental Implant in Daily Practice

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05016258
Enrollment
159
Registered
2021-08-23
Start date
2022-01-26
Completion date
2025-10-31
Last updated
2023-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implant, Dental Restoration, Dentistry, Implant-supported Fixed Prosthesis

Keywords

Mono Block design, KONTACT MB, Biotech Dental

Brief summary

A multicenter prospective observational study aims to illustrate the clinical outcome of dental implants Kontact MB and the effects of its Mono Block design on the peri implant bone tissue recession and soft tissue conservation. All the enrolled patients will be eligible for one or multiple implant-supported fixed restoration(s) according to the routine clinical practice and the manufacturer's instruction for use.

Interventions

DEVICEKONTACT MB

Dental implant surgery

Sponsors

Biotech Dental
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Edentulous patient (partially or completely AND formerly, recently or just before implantation) requiring the placement of one (or more) dental implant (s) in maxillary or mandibular * Age ≥ 18 years * Good general health (ASA score between \[1-2\]) * Sufficient bone volume and quality (with or without bone graft) to support the implant * Given a writing consent for the collection of his medical data as part of the study (delivery of a patient's sheet)

Exclusion criteria

* Poor oral hygiene * Bruxism, parafunctional habits, occlusion disorders and / or temporomandibular joints * Infections and oral inflammation such as periodontitis, gingivitis * Patient with metabolic disorders (eg diabetes mellitus) or bone disease that may compromise peri-implant tissue healing * Heavy smoker (\> 10 cigarettes / day) * Patient with a pathology or immunosuppressive therapy such as chemotherapy, radiotherapy * Patient on prolonged steroid therapy * Titanium / titanium alloy allergy * Alcohol or drug abuse * Pregnant woman (or likely to be pregnant); or breastfeeding * Difficulty of medical follow-up patients with geographical, social or psychological constraints * Persons deprived of liberty or guardianship * Involuntary / patient refusal to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Implant survival rateup to 36 monthsNumber of implants still in function up to 36 months post implantation
Peri implant bone levelup to 36 monthsBone level evolution compare to the bone level at implantation day
Keratinized tissues levelup to 36 monthsAssessment of keratinized tissues
Gingival indexup to 36 monthsGingival index assess with Loë and Silness Score
Bleeding indexup to 36 monthsBleeding index on probing following the Mombelli score

Countries

France

Contacts

Primary ContactCécile Reynès
c.reynes@biotech-dental.com(0)626110768
Backup ContactPascal Breysse
p.breysse@biotech-dental.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026